Podcast Episodes
Back to Search
The next big shake-up in the GLP-1 market? (Part 1 of 3)
Episode 219
Welcome to a special three-part series called 'The Metabolic Moment'.
In just a few years, GLP-1 drugs have become a phenomenon. They’ve transformed h…
4 hours ago
Saudi Arabia's biotech momentum: inside RGMBS 2026
Episode 218
Saudi Arabia has spent the last four years building one of the most ambitious biotech gatherings in the region: the Riyadh Global Medical Biotechnolo…
1 week ago
How Flagship's Valo is reshaping AI drug discovery with human data
Episode 217
AI has been one of the biggest buzzwords in biotech for years now — but for all the technological progress, actual R&D productivity gains have been h…
2 weeks ago
Theialife’s race to bring a childhood myopia treatment to market
Episode 216
By 2050, nearly half the world's population is expected to be myopic, with around a billion people projected to progress to high myopia — a leading c…
3 weeks ago
The best biotech conversations you missed this summer
Episode 215
Summer is a busy time for everyone, guests and listeners alike, so today we're taking stock. This is our Summer Recap — a clips episode pulling toget…
4 weeks ago
Rewriting the rules of genetic medicine with tRNA therapeutics
Episode 214
Most genetic medicines are built to treat one gene, one mutation, one disease at a time. That's true even for the newest modalities — gene therapy, g…
1 month ago
How Evox Therapeutics is targeting CNS diseases with exosomes
Episode 213
Gene therapy has largely stayed out of the brain, and the blood-brain barrier has been the reason why — it protects the brain from harm, but it also …
1 month, 1 week ago
BIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech
Episode 212
Today we’re thrilled to bring you a special episode highlighting one of Europe’s premier biotechnology events: BIOSPAIN 2026.
Joining us is Stuart Med…
1 month, 2 weeks ago
Beyond biology: Nanobiotix's physics-first approach to cancer
Episode 211
What if the key to beating cancer wasn't a new drug, but a new way of thinking about matter itself? That's the question Laurent Lévy asked when he co…
1 month, 3 weeks ago
How Cancer Research Horizons is building the future of childhood cancer medicines
Episode 210
Cancer is still the leading cause of death by disease in children and young people — yet in the last twenty years, only a handful of drugs have been …
2 months ago